We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at ...

Currently trading with a volume of 891,270, the VRTX's price is down by -3.75%, now at $451.64. RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” third ...

Price Action: VRTX stock is up 2.16% at $472.06 at last check Monday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...

Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...

But when something this big happens with VRTX, it often means somebody knows ... Smart Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a global leader in cystic ... However, the company developed its competitive edge with the Trikafta treatment getting approved in 2019.